Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2009 | 10-2008 | 10-2007 | 10-2006 | 10-2005 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5 | 6 | 8 | 19 | 36 |
| Accounts receivable | 2 | -37 | 12 | 165 | -109 |
| Accounts payable and accrued liabilities | N/A | -20 | N/A | N/A | N/A |
| Other Working Capital | 52 | -76 | 31 | 301 | -165 |
| Other Operating Activity | -56 | 25 | -196 | -439 | 181 |
| Operating Cash Flow | $3 | $-102 | $-145 | $47 | $-57 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1 | N/A | 9 | N/A |
| Investing Cash Flow | $0 | $-1 | $0 | $9 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 224 | 100 | N/A | N/A |
| Other Financing Activity | 0 | -61 | 147 | -54 | -16 |
| Financing Cash Flow | $0 | $163 | $247 | $-54 | $-16 |
| Beginning Cash Position | 177 | 116 | 15 | 12 | 85 |
| End Cash Position | 179 | 177 | 116 | 15 | 12 |
| Net Cash Flow | $2 | $61 | $102 | $2 | $-73 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3 | -102 | -145 | 47 | -57 |
| Capital Expenditure | 0 | -1 | N/A | N/A | N/A |
| Free Cash Flow | 2 | -103 | -145 | 47 | -57 |